Wednesday morning, Kazia Therapeutics Limited KZIA announced the early conclusion based on safety and clinical response findings observed to date of an…
Glioma Clinical Trial Pipeline Insights | 200+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce the appointment of pharma.